22 Aug 2017 - 6:26am

Call us: +44 (0) 207 754 0050

Press Releases in Medical

Expansion of Global Clinical Trials for Treating an Array of Rare Diseases Boosting Market Growth

 [PRESSWIRE] PALM BEACH, Florida, June 15, 2017 --Clinical Trials for orphan drugs have shown tremendous potential in diagnosis and treatment of cancer with an increase in indications to treat an array of different diseases such as lymphoma, leukemia, myeloma, and others to boost the market growth potential for biotechs and pharmaceutical companies alike.

First-time exhibitors debut at Medtec China, Siemens PLM and FDA support onsite conference

 [PRESSWIRE] SHANGHAI, June 6, 2017 -- Medtec China has been dedicating to serving as a high quality community for medical device R&D and production technology field, and providing innumerable ideas and possibilities for the development of China's local medical device manufacturers and support for multinational medical device manufacturers to set up production and R&D bases in China since the first show in 2005.

HARTMANN Group to Acquire P&G Incontinence Brand in Spain/Portugal

[PRESSWIRE] HEIDENDHEIM, Germany, March 2, 2017 --The HARTMANN GROUP, a leading international supplier of medical and hygiene products, announced today it plans to acquire Procter & Gamble's Lindor -- one of the most well-known adult incontinence brands in the Spain and Portugal professional channel. The transaction seeks to take place by end of second quarter of fiscal year 2017 and is subject to approval by local antitrust authorities.  

Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry

[PRESSWIRE] SANTA CLARA, California, Feb. 9, 2017 -- A confluence of innovative technologies moving from concept to reality correlated with macroeconomic factors such as cost of care constraints, consumerism, and connectivity are leading to a replacement of outdated models of care with precision medicine approaches. Moving beyond just genomics, developers have begun to examine a wider range of patient records that apprehends everything from remote monitoring to consumer data streams.

CALCIVIS Starts Clinical Study to Support FDA Filing in H2 2017

[PRESSWIRE] EDINBURGH, Scotland, January 9, 2017 -- CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that it has begun recruitment into a clinical study of approximately 100 patients assessing the performance of a commercial version of its CE marked CALCIVIS® imaging system across four general dental practices in Scotland.


Subscribe to Press Releases in Medical